Aberdeen life sciences spin-out Saccade Diagnostics secures £1.4m award from Department of Health and Wellcome Trust.
Buffalo spin-out Empire Genomics looks to raise $15m for cancer diagnostics.
MIT wireless energy transfer firm WiTricity announce two hires to senior leadership team.
Teva implants $35m in Microchips Biotech
The cash is being provided in the form of equity and an access fee as the two companies form a partnership agreement to improve drug delivery systems.
Utah spin-out ProMD acquired by SilverVue for unspecified sum
ProMD, a spin-out of Utah University developing a platform for post-hospital aftercare, has been acquired by telehealth technology firm SilverVue.
Gesture recognition firm Rithmio, a spin-out of University of Illinois at Urbana-Champaign, raises $3m seed round.
908 Devices, backed by Arch and Tokyo University, increases C round to $13m.
Virginia’s TypeZero secures seed via Centre for Innovative Technology.
Celgene sees billion dollar potential at Juno
Biotech giant Celgene invests $1bn into immunotherapy leader Juno Therapeutics.
Sunamp renews investor interest in series B
Renewable energy firm Sunamp attracts Old College Capital and others in $2m series B.
Kepler eyes tidal energy in the Severn
Oxford spin-out Kepler Energy reveals plans for £143m tidal fence in Severn Estuary.
Travel media startup Family Traveller secures £750,000 in round backed by Cass Entrepreneurship Fund.
Innovations quickens the pace on licensing
Imperial Innovations marks its first deal through its online licensing portal Quicktech.
Oxford life sciences spin-out Orthox secures round from Isis Fund and Parkwalk.
Imperial moves £3m to Abingdon
Abingdon Health secures £3m ($4.7m) in venture round backed by existing investor Imperial Innovations.
KAUST’s seeds grow into innovation
KAUST upgrades its seed fund to innovation fund looking to invest up to $2m in early-stage KAUST firms.
Patents’ minimal impact on innovation
Stanford study fails to find strong link between patent licensing and innovation.
Novo exits Spinifex in $200m Novartis acquisition
Queensland’s Spinifex sells to Novartis for $200m.
MIT spin-out SQZ Biotech raises $5m in series A to develop cell squeezing technology.
Golden shares and anti-dilution provisions
Leaders from two of the UK’s biggest TTOs, Isis and Imperial, discuss the university “golden share” in spin-out companies.
